Enrique A. Conterno, SVP&Pres, Lilly Diab & Lilly USA at LILLY ELI & CO (LLY), sold 50,000 shares at $82.76 ($4.1M) on 2017-05-04, disclosed to the SEC on 2017-05-08.
Open-market sale of $4.1M LLY by SVP&Pres, Lilly Diab & Lilly USA. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.76 | 25,000 | $2.1M | 50.0% |
| 2 | $82.76 | 25,000 | $2.1M | 50.0% |
| Total | $82.76 avg | 50,000 | $4.1M | 100% |
| Filing → |
| FGEN | SELL | 2023-04-11 | $36K | — | Filing → |
| FGEN | SELL | 2023-03-23 | $787K | — | Filing → |
| FGEN | SELL | 2023-03-10 | $1.7M | — | Filing → |